Matches in Wikidata for { <http://www.wikidata.org/entity/Q62660976> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q62660976 description "article scientifique publié en 2018" @default.
- Q62660976 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q62660976 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q62660976 description "scientific article published on 25 August 2018" @default.
- Q62660976 description "wetenschappelijk artikel" @default.
- Q62660976 description "наукова стаття, опублікована в серпні 2018" @default.
- Q62660976 name "Serum 5-S -cysteinyldopa behavior in the early phase of nivolumab treatment of 12 melanoma patients" @default.
- Q62660976 name "Serum 5-S -cysteinyldopa behavior in the early phase of nivolumab treatment of 12 melanoma patients" @default.
- Q62660976 type Item @default.
- Q62660976 label "Serum 5-S -cysteinyldopa behavior in the early phase of nivolumab treatment of 12 melanoma patients" @default.
- Q62660976 label "Serum 5-S -cysteinyldopa behavior in the early phase of nivolumab treatment of 12 melanoma patients" @default.
- Q62660976 prefLabel "Serum 5-S -cysteinyldopa behavior in the early phase of nivolumab treatment of 12 melanoma patients" @default.
- Q62660976 prefLabel "Serum 5-S -cysteinyldopa behavior in the early phase of nivolumab treatment of 12 melanoma patients" @default.
- Q62660976 P1433 Q62660976-A71DFC25-9FF9-470F-9939-A2C842784550 @default.
- Q62660976 P1476 Q62660976-CE7C6C30-6AB1-4813-B9C6-8882C44B8811 @default.
- Q62660976 P2093 Q62660976-03B00EFE-E60F-4D97-B954-B904CF2FA3B8 @default.
- Q62660976 P2093 Q62660976-2F368E83-97A3-4675-8AA9-3AD418031316 @default.
- Q62660976 P2093 Q62660976-6C623DAA-A772-401A-B466-94932943F1E4 @default.
- Q62660976 P2093 Q62660976-D84BAEAB-7031-4C95-97CA-814E6606B385 @default.
- Q62660976 P304 Q62660976-DAF060F4-C181-4170-A78E-415B41982049 @default.
- Q62660976 P31 Q62660976-4DABADBB-42F3-4A3A-B02C-8E33867CF05A @default.
- Q62660976 P356 Q62660976-A87C95CD-E09C-4DA1-82D7-C3D70A9AAE64 @default.
- Q62660976 P433 Q62660976-7A319A4B-DB5A-4A8B-9256-A50B451B639F @default.
- Q62660976 P478 Q62660976-EB8A4502-F25A-48E6-ADE0-82B48E187FB5 @default.
- Q62660976 P50 Q62660976-0F04D1F7-1BEE-486B-BABF-6994B3F64698 @default.
- Q62660976 P50 Q62660976-17147788-FFC6-47A7-B673-9D32198EE757 @default.
- Q62660976 P50 Q62660976-5DCED9B4-ABBA-4FE2-A734-28CA88A94184 @default.
- Q62660976 P50 Q62660976-B75B4B5B-379E-4FD7-8949-F661359A8F8D @default.
- Q62660976 P577 Q62660976-7F552D7D-5BCA-4024-9797-1F5C5DBC69C0 @default.
- Q62660976 P698 Q62660976-4C45F714-271E-4EF6-9E01-9EE476F84E27 @default.
- Q62660976 P356 1346-8138.14605 @default.
- Q62660976 P698 30144152 @default.
- Q62660976 P1433 Q18225322 @default.
- Q62660976 P1476 "Serum 5-S-cysteinyldopa behavior in the early phase of nivolumab treatment of 12 melanoma patients" @default.
- Q62660976 P2093 "Hisashi Uhara" @default.
- Q62660976 P2093 "Ryuhei Okuyama" @default.
- Q62660976 P2093 "Toshikazu Omodaka" @default.
- Q62660976 P2093 "Yoshiharu Yokokawa" @default.
- Q62660976 P304 "1340-1344" @default.
- Q62660976 P31 Q13442814 @default.
- Q62660976 P356 "10.1111/1346-8138.14605" @default.
- Q62660976 P433 "11" @default.
- Q62660976 P478 "45" @default.
- Q62660976 P50 Q30512049 @default.
- Q62660976 P50 Q62670691 @default.
- Q62660976 P50 Q79913118 @default.
- Q62660976 P50 Q89952889 @default.
- Q62660976 P577 "2018-08-25T00:00:00Z" @default.
- Q62660976 P698 "30144152" @default.